Levels of Evidence of Carcinogenicity

[1]  S. James Adelstein,et al.  The physician's responsibility toward hopelessly ill patients. , 1989, The New England journal of medicine.

[2]  S. Peters,et al.  Outcome of respiratory failure in hematologic malignancy. , 1988, Chest.

[3]  T. Lister,et al.  Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy , 1988, British medical journal.

[4]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[5]  Mark H. Johnson,et al.  Stratification of prognosis in granulocytopenic patients with hematologic malignancies using the APACHE‐II severity of illness score , 1986, Critical care medicine.

[6]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[7]  W. Knaus,et al.  Precedents for meaningful recovery during treatment in a medical intensive care unit. , 1984, The American journal of medicine.

[8]  H. Baier,et al.  Survival of patients with cancer in a medical critical care unit. , 1982, Archives of internal medicine.

[9]  A S Detsky,et al.  Prognosis, survival, and the expenditure of hospital resources for patients in an intensive-care unit. , 1981, The New England journal of medicine.

[10]  G O Barnett,et al.  Medical intensive care: indications, interventions, and outcomes. , 1980, The New England journal of medicine.

[11]  G. Carlon,et al.  The inverse relationship between cost and survival in the critically ill cancer patient , 1979, Critical care medicine.

[12]  D. Cullen,et al.  Survival, hospitalization charges and follow-up results in critically ill patients. , 1976, New England Journal of Medicine.

[13]  S. James Adelstein,et al.  The physician's responsibility toward hopelessly ill patients. , 1989, The New England journal of medicine.

[14]  S. Peters,et al.  Outcome of respiratory failure in hematologic malignancy. , 1988, Chest.

[15]  T. Lister,et al.  Prognosis of patients receiving intensive care for lifethreatening medical complications of haematological malignancy , 1988, British medical journal.

[16]  G. Huston.  The Hospital Anxiety and Depression Scale. , 1987, The Journal of rheumatology.

[17]  H. Heimpel,et al.  Intensive care therapy for patients with hematological diseases. , 1987, Haematology and blood transfusion.

[18]  Mark H. Johnson,et al.  Stratification of prognosis in granulocytopenic patients with hematologic malignancies using the APACHE‐II severity of illness score , 1986, Critical care medicine.

[19]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[20]  W. Knaus,et al.  Precedents for meaningful recovery during treatment in a medical intensive care unit. , 1984, The American journal of medicine.

[21]  H. Baier,et al.  Survival of patients with cancer in a medical critical care unit. , 1982, Archives of internal medicine.

[22]  A S Detsky,et al.  Prognosis, survival, and the expenditure of hospital resources for patients in an intensive-care unit. , 1981, The New England journal of medicine.

[23]  G O Barnett,et al.  Medical intensive care: indications, interventions, and outcomes. , 1980, The New England journal of medicine.

[24]  M. Ali,et al.  Respiratory failure in cancer patients. , 1979, JAMA.

[25]  G. Carlon,et al.  The inverse relationship between cost and survival in the critically ill cancer patient , 1979, Critical care medicine.

[26]  D. Cullen,et al.  Survival, hospitalization charges and follow-up results in critically ill patients. , 1976, New England Journal of Medicine.

[27]  W. Sibbald,et al.  Acute respiratory failure , 1976, Critical care medicine.